, /PRNewswire/ -- TETROUS, INC., a start up focused on bone-to-tendon healing following orthopedic surgery, announced today that it was the sole recipient of this year's ACE Award for "Accelerating the Cutting Edge" at the recent AOSSM annual conference held in , CO. Although this honor is typically given to 2 or 3 innovative technologies in the industry, this year the committee stated the EnFix technology is a true "game changer" and presented Tetrous as the sole recipient.
"We are truly grateful for this award from AOSSM" stated , PhD, co-founder and CTO of Tetrous. He continued, "We have worked diligently in creating a technology that directly addresses the current high rate of failure in rotator cuff surgeries and other orthopedic procedures by remodeling the enthesis, the region where the tendon attaches to the bone. It is very rewarding that the industry is recognizing this unique technology.
" More than 500 EnFix RCTM and EnFix TACTM have been implanted in a controlled release in the US and over the past 12 months. Follow up MRIs on patients at six months post-surgery are consistently showing reformation of the enthesis, thickening of the tendon and little to no edema. While the majority of the procedures have been for rotator cuff, there are additional applications for this technology in hip, achilles and ACL procedures.
"We reviewed applications from a wide variety of companies for the 2024 ACE award," stated Dr. , orthopaedic surgeon and ACE award committee member. ".